A Phase IIIB Multi-center, Randomized, Double-Blind Study to Evaluate Remission and Joint Damage Progression in Methotrexate Naive Early Erosive RA Subjects Treated With Abatacept Plus Methotrexate Compared With Methotrexate
A Phase IIIB Multi-center, Randomized, Double-Blind Study to Evaluate Remission and Joint Damage Progression in Methotrexate Naive Early Erosive RA Subjects Treated With Abatacept Plus Methotrexate Compared With Methotrexate
This is a world wide study to evaluate the remission and joint damage in subjects treated with abatacept in addition to methotrexate versus subjects who receive methotrexate along with a placebo.
Inclusion Criteria:
Exclusion Criteria:
Rio de Janeiro - Rj, Rio de Janeiro 20551, Brazil
D.f., Mexico City 06700, Mexico
Muckleneuk, Gauteng 0002, South Africa
Panorama, Western Cape 7506, South Africa